Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Promoter methylation and polymorphism of E-cadherin gene may confer a risk to prostate cancer: a meta-analysis based on 22 studies.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Oct 2014

Chang Zheng, Zhou Hongbing, Liu Yi

Abstract excerpt

Emerging evidence has suggested that -160C/A polymorphism and promoter methylation of E-cadherin gene may contribute to the risk of prostate cancer. However, the results are still conflicting. We aim to systematically evaluate the potential of promoter methylation and polymorphism in E-cadherin gene to confer a risk to prostate cancer through meta-analysis. PubMed, Embase, Web of Science, Cochrane Library, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cadherins
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Polymorphism, Single Nucleotide

Share to Promoter Regions, Genetic

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Identifiers

PMID: 25056535
DOI: 10.1007/s13277-014-2323-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Promoter methylation and polymorphism of E-cadherin gene may confer a risk to prostate cancer: a meta-analysis based on 22 studies.PMID 25056535Read ↗

Contribution of the -160C/A polymorphism in the E-cadherin promoter to cancer risk: a meta-analysis of 47 case-control studies.Semantic proximity Read ↗

The E-cadherin (CDH1)--160 C/A polymorphism and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

The E-cadherin gene polymorphism 160C->A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies.Semantic proximity Read ↗

Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer.Semantic proximity Read ↗

Recent advances in understanding DNA methylation of prostate cancerSemantic proximity Read ↗

DNA Methylation in Prostate Cancer: Clinical Implications and Potential ApplicationsSemantic proximity Read ↗

Promoter Hypermethylation in Prostate CancerSemantic proximity Read ↗

Association of G/A polymorphism, rs266882, in AREI region of the prostate-specific antigen gene with prostate cancer risk and clinicopathological features.Semantic proximity Read ↗

The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men.Semantic proximity Read ↗

Association between APE1 T1349G polymorphism and prostate cancer risk: evidence from a meta-analysis.Semantic proximity Read ↗

E-cadherin promoter polymorphisms are not associated with the aggressiveness of prostate cancer in Caucasian patients.Semantic proximity Read ↗

Update analysis on the association between Methionine synthase rs1805087 A/G variant and risk of prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.